Manning & Napier Group LLC Has $7.37 Million Stock Position in Coca-Cola European Partners PLC (NYSE:CCEP)

Share on StockTwits

Manning & Napier Group LLC lowered its position in shares of Coca-Cola European Partners PLC (NYSE:CCEP) by 3.5% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 132,924 shares of the company’s stock after selling 4,780 shares during the quarter. Manning & Napier Group LLC’s holdings in Coca-Cola European Partners were worth $7,369,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Enterprise Financial Services Corp acquired a new stake in shares of Coca-Cola European Partners during the second quarter worth $25,000. FTB Advisors Inc. acquired a new position in Coca-Cola European Partners in the second quarter valued at about $25,000. Zions Bancorporation N.A. acquired a new position in Coca-Cola European Partners in the second quarter valued at about $26,000. SevenBridge Financial Group LLC acquired a new position in Coca-Cola European Partners in the second quarter valued at about $26,000. Finally, Pearl River Capital LLC acquired a new position in Coca-Cola European Partners in the second quarter valued at about $29,000. 29.17% of the stock is owned by institutional investors.

CCEP stock opened at $56.51 on Friday. The company has a market cap of $27.08 billion, a PE ratio of 20.78, a price-to-earnings-growth ratio of 2.23 and a beta of 0.41. The business has a 50-day simple moving average of $55.66 and a 200 day simple moving average of $55.19. Coca-Cola European Partners PLC has a 52 week low of $42.69 and a 52 week high of $58.35. The company has a quick ratio of 0.62, a current ratio of 0.84 and a debt-to-equity ratio of 0.90.

CCEP has been the subject of a number of analyst reports. Evercore ISI reaffirmed a “buy” rating and issued a $60.00 price target on shares of Coca-Cola European Partners in a research note on Thursday, August 8th. Barclays set a $60.00 price target on Coca-Cola European Partners and gave the company a “buy” rating in a research note on Friday, August 9th. ABN Amro raised Coca-Cola European Partners from a “sell” rating to a “hold” rating in a research note on Tuesday, August 13th. ValuEngine downgraded Coca-Cola European Partners from a “sell” rating to a “strong sell” rating in a research note on Wednesday, October 2nd. Finally, Zacks Investment Research downgraded Coca-Cola European Partners from a “hold” rating to a “sell” rating in a research note on Monday, October 7th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and four have given a buy rating to the company’s stock. Coca-Cola European Partners currently has a consensus rating of “Hold” and an average price target of $55.20.

Coca-Cola European Partners Company Profile

Coca-Cola European Partners plc, together with its subsidiaries, produces, markets, distributes, and sells a range of nonalcoholic ready-to-drink beverages. The company offers sparkling flavors, energy drinks, juices, isotonics, and other drinks, as well as water. It provides its products primarily under the Coca-Cola, Fanta, and Sprite brands, as well as Coca-Cola Zero Sugar, Mezzo Mix, Schweppes, Royal Bliss, Fïnle, Monster, GLACÉAU Smartwater, Vio, Chaudfontaine, Fuze Tea, Honest Coffee, Oasis, Capri-Sun, Honest, and Tropico brands.

See Also: What is a stock split?

Want to see what other hedge funds are holding CCEP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Coca-Cola European Partners PLC (NYSE:CCEP).

Institutional Ownership by Quarter for Coca-Cola European Partners (NYSE:CCEP)

Receive News & Ratings for Coca-Cola European Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coca-Cola European Partners and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.